Value
4.3/10data confidence 100%| Component | Sub-score |
|---|---|
| P/E | 2.8 |
| P/S | 9.4 |
| EV/EBITDA | 0.0 |
| Fwd P/E | 5.2 |
| PEG | 4.3 |
| Analyst target | 4.0 |
- ▸Forward P/E: 24.2x
- ▸PEG: 2.22
PNTG · Why this verdict
Why The Pennant Group (PNTG) is rated SELL
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
VerdictSELL
Overall score5.6/10
ConfidenceMEDIUM
MacroNEUTRAL
Thesis pillars
| Pillar | Expectation | Trend |
|---|---|---|
Pennant Group's quality score of 3.4 out of 10 falls below the minimum investable threshold of 4.0, with operating margins at a very low level (operating margin score 2.4/10), no competitive moat, and earnings quality warning where free cash flow represents only 63% of net income. Quality breakdown | Quality score improves above 4.0 within 12 months as the company achieves scale in its services business that drives margin expansion. | →Stable |
| CounterHealthcare services businesses that are growing at 36% often experience temporary margin compression during rapid expansion as they hire staff and open new facilities — the quality issue may resolve naturally as growth matures. | ||
Pennant Group is growing revenue at 36% year-over-year, ranking as an industry growth leader within medical care facilities with a near-perfect growth score of 10/10 on revenue growth, indicating strong demand for its home health, hospice, and senior living services. Growth breakdown | Revenue growth remains above 25% year-over-year for the next 12 months as the company continues expanding its senior care facility network. | →Stable |
| CounterHealthcare services revenue growth at 36% can be misleading when driven primarily by acquisitions rather than organic growth; high growth companies in regulated healthcare are exposed to reimbursement rate changes that can instantly reverse revenue trajectories. | ||
The insider score of 7.2/10 reflects institutions actively accumulating Pennant Group shares — holder change scored 10/10 with notable institutional moves at 7.0/10 — suggesting sophisticated investors are building positions despite the quality concerns. Insider breakdown | Institutional ownership increases by at least 3 percentage points within 12 months as the growth thesis attracts more institutional capital. | →Stable |
| CounterInstitutional accumulation in small-cap healthcare companies with below-floor quality scores can reflect early-stage speculation rather than fundamental conviction, and institutions can also exit rapidly if the quality concerns materialize into earnings problems. | ||
The put/call ratio of 6.00 is the highest in this analysis batch — six puts for every one call option outstanding — indicating extreme bearish positioning in the options market, which creates downside risk amplification if negative catalysts emerge and puts are exercised. Key risks | Put/call ratio falls below 2.0 within 6 months as bearish hedgers reduce their protective positions following positive earnings results. | →Stable |
| CounterExtreme put/call ratios can be contrarian buy signals — when bearish sentiment reaches extreme levels, the market may be over-positioned for downside and a positive catalyst could trigger a disproportionate upside move. | ||
Pennant Group's quality score of 3.4 out of 10 falls below the minimum investable threshold of 4.0, with operating margins at a very low level (operating margin score 2.4/10), no competitive moat, and earnings quality warning where free cash flow represents only 63% of net income.
→StableQuality breakdown
- Expectation
- Quality score improves above 4.0 within 12 months as the company achieves scale in its services business that drives margin expansion.
CounterHealthcare services businesses that are growing at 36% often experience temporary margin compression during rapid expansion as they hire staff and open new facilities — the quality issue may resolve naturally as growth matures.
Pennant Group is growing revenue at 36% year-over-year, ranking as an industry growth leader within medical care facilities with a near-perfect growth score of 10/10 on revenue growth, indicating strong demand for its home health, hospice, and senior living services.
→StableGrowth breakdown
- Expectation
- Revenue growth remains above 25% year-over-year for the next 12 months as the company continues expanding its senior care facility network.
CounterHealthcare services revenue growth at 36% can be misleading when driven primarily by acquisitions rather than organic growth; high growth companies in regulated healthcare are exposed to reimbursement rate changes that can instantly reverse revenue trajectories.
The insider score of 7.2/10 reflects institutions actively accumulating Pennant Group shares — holder change scored 10/10 with notable institutional moves at 7.0/10 — suggesting sophisticated investors are building positions despite the quality concerns.
→StableInsider breakdown
- Expectation
- Institutional ownership increases by at least 3 percentage points within 12 months as the growth thesis attracts more institutional capital.
CounterInstitutional accumulation in small-cap healthcare companies with below-floor quality scores can reflect early-stage speculation rather than fundamental conviction, and institutions can also exit rapidly if the quality concerns materialize into earnings problems.
The put/call ratio of 6.00 is the highest in this analysis batch — six puts for every one call option outstanding — indicating extreme bearish positioning in the options market, which creates downside risk amplification if negative catalysts emerge and puts are exercised.
→StableKey risks
- Expectation
- Put/call ratio falls below 2.0 within 6 months as bearish hedgers reduce their protective positions following positive earnings results.
CounterExtreme put/call ratios can be contrarian buy signals — when bearish sentiment reaches extreme levels, the market may be over-positioned for downside and a positive catalyst could trigger a disproportionate upside move.
TrendMatrix Research · core thesis
Engine thesis — one sentence
The Pennant Group is a healthcare services provider with 36% revenue growth and strong analyst consensus support, but a quality score of 3.4 out of 10 below the investable floor, an elevated put/call ratio of 6.00, and an asymmetry ratio of 0.74 that does not justify new risk at current prices near $33.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
Per-dimension breakdown
Quality
3.4/10data confidence 100%| Component | Sub-score |
|---|---|
| ROE | 3.3 |
| ROA | 2.7 |
| Gross margin | 0.0 |
| Op margin | 2.4 |
| Net margin | 1.5 |
| Current ratio | 4.6 |
| FCF quality | 4.9 |
| Moat | 4.9 |
| Piotroski F | 6.7 |
- ▸Earnings quality warning: 63% FCF/NI
- ▸No competitive moat
Growth
6.9/10data confidence 67%| Component | Sub-score |
|---|---|
| Rev growth | 10.0 |
| EPS growth | 3.8 |
- ▸Strong growth: 36% YoY
Momentum
8.5/10data confidence 100%| Component | Sub-score |
|---|---|
| RSI | 3.7 |
| MACD | 10.0 |
| OBV | 10.0 |
| MA position | 9.0 |
| Volume | 9.7 |
- ▸Overbought (RSI 86)
- ▸Volume accumulation (rising OBV)
- ▸Above 200-day MA
Sentiment
6.3/10data confidence 100%| Component | Sub-score |
|---|---|
| Analyst rating | 7.6 |
| Price target | 5.9 |
| erm sentiment | 5.0 |
- ▸Light analyst coverage (6.0) — signal dampened
Insider
7.3/10data confidence 75%| Component | Sub-score |
|---|---|
| materiality | 5.0 |
| holder change | 10.0 |
| notable moves | 7.0 |
- ▸Insider selling (low materiality) — $158,140 (0.012% of mkt cap)
- ▸Institutions accumulating
Peer rank
3.7/10data confidence 80%| Component | Sub-score |
|---|---|
| value rank | 2.7 |
| quality rank | 4.0 |
| growth rank | 8.3 |
- ▸Industry growth leader
Technical
3.9/10data confidence 100%| Component | Sub-score |
|---|---|
| bollinger | 0.0 |
| support resistance | 0.9 |
| 52w position | 9.5 |
| gap | 5.0 |
Risk (lower is worse)
5.8/10data confidence 100%| Component | Sub-score |
|---|---|
| short interest | 9.0 |
| days to cover | 8.2 |
| volatility | 3.1 |
| put call | 8.3 |
| implied vol | 1.2 |
| beta | 6.0 |
| debt equity | 4.7 |
- ▸High IV: 73%
- ▸Concentration risks: 2 HIGH, 1 MED (10-K Item 1A — sized via position_sizing, validated via buy_confidence)
Catalyst
6.3/10data confidence 100%| Component | Sub-score |
|---|---|
| erm | 5.0 |
| earnings history | 10.0 |
| earnings timing | 5.0 |
| surprise avg | 5.4 |
- ▸Strong earnings: 3B/0M
How the verdict was assembled
Engine trigger
Quality below minimum threshold.
Engine technical detail
verdict_path:
L1:HARD_BLOCKPassed (7)
- MOMENTUM:8.5>=5.5
- INSIDER:OK
- 8K:CLEAN
- NEWS_EVENTS:NONE_RECENT
- EARNINGS_PROXIMITY:31d clear
- SEMI_CYCLE_PEAK:CLEAR
- MATERIALS_CYCLE_PEAK:CLEAR
Failed (1)
- ASYMMETRY:-0.5=NEGATIVE
Warning (0)
none
Reward-to-Risk
-0.52
Upside
-7.8%
Downside
15.0%
Sizing output
AVOID
Setup— — No clear chart pattern; technical signals are mixed
EdgeNo clear edge — No clear edge identified
SuitabilityAggressive — MCap $1.3B<$5B
Investment implication
The L1 gate blocked the positive-verdict path: a hard-floor threshold was breached, so dimensional pillars — including Momentum at 8.5 could not lift the engine output above the verdict floor. Failed gate signal: ASYMMETRY:-0.5=NEGATIVE.
The strongest dimensions are Momentum at 8.5, Insider at 7.3, and Growth at 6.9; the weakest are Quality at 3.4, Peer rank at 3.7, and Technical at 3.9. The V9 engine flagged 1 failed gate, producing an asymmetric reward-to-risk of -0.52 and an engine sizing output of AVOID.
What would invalidate the thesis
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1Strong Revenue Growth Rate
Trip ifRevenue growth falls below 20% year-over-year for 2 consecutive quarters.
- P2Institutional Accumulation Signal
Trip ifInstitutional ownership declines by more than 5 percentage points over 6 months, signaling distribution.
- P3Quality Below Investable Floor
Trip ifQuality score remains below 3.0 for 4 consecutive quarters with no improvement in operating margins above 5%.
- P4Elevated Options Risk Signal
Trip ifPut/call ratio rises above 8.0, indicating further acceleration in bearish hedging that precedes institutional selling.